PTK2 and neoplasm: In line with these findings, the cell invasion and tumor growth of NSCLC tumors were hampered in α11-/- xenograft NSCLC models[91], followed by diminished stiffness of tumor stroma and downregulation of focal adhesion kinase (FAK) and protein tyrosine kinase 2 (PTK2) activity.